Document Detail


Two sensitive echocardiographic techniques for detecting doxorubicin toxicity.
MedLine Citation:
PMID:  6855698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This investigation was designed to evaluate echoes of patients who received a course of doxorubicin (225-550 mg/m2) by two sensitive indicators of myocardial fibrosis: (1) M-mode scans of thickening-thinning curves of the left ventricular posterior wall (LVPW), and (2) two-dimensional qualitative evaluation of LVPW contraction at three levels of the LV short axis (leaflet, chordal, and papillary). These were compared to standard M-mode shortening fraction (delta S). Eighteen children with cancer were evaluated; 11 had received doxorubicin and 7 were treated with other agents. Echocardiographers were unaware of the treatment category. All controls and 10 of 11 doxorubicin patients had normal delta S. An M-mode echocardiogram of the expanded LVPW was digitized and wall thickness was evaluated by determining if diastolic relaxation had the normal two phases or only one; six of ten doxorubicin patients and no controls had abnormal relaxation. Qualitative evaluation of LVPW and septal contraction toward the center of the ventricle showed that seven of eleven patients who received doxorubicin and one control (a postthoracotomy patient) had contraction deficits. Six of seven with contraction deficit were the same patients with slowed relaxation. The greatest contraction deficit occurred in the LVPW behind the posterior mitral leaflet. Patients with more extensive involvement had an additional contraction deficit extending to the apex. These tests are more sensitive for detection of doxorubicin toxicity than delta S.
Authors:
S J Goldberg; J J Hutter; L Feldman; S M Goldberg
Related Documents :
1572188 - Right ventricular dysfunction in septic patients.
12822748 - Electrocardiographic ventricular repolarization parameters in chronic chagas' disease a...
6829398 - Chronic recurrent right ventricular tachycardia in patients without ischemic heart dise...
17940858 - Reversal of dilated cardiomyopathy by the elimination of frequent left or right prematu...
22559288 - Patients with unstable angina pectoris show an increased frequency of the fc gamma riia...
1824928 - Adenosine deaminase in the diagnosis of tuberculous pleural effusions. a report of 218 ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Medical and pediatric oncology     Volume:  11     ISSN:  0098-1532     ISO Abbreviation:  Med. Pediatr. Oncol.     Publication Date:  1983  
Date Detail:
Created Date:  1983-07-29     Completed Date:  1983-07-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7506654     Medline TA:  Med Pediatr Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  172-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cardiomyopathies / chemically induced*,  physiopathology
Child
Child, Preschool
Doxorubicin / adverse effects*
Echocardiography / methods*
Heart / physiopathology
Humans
Chemical
Reg. No./Substance:
23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuroblastoma: therapy for infants with good prognosis.
Next Document:  Identification of an apparent aminoacyl-tRNA synthetase activator factor as tRNA nucleotidyltransfer...